Sentences with phrase «clinical studies at»

Dr. Gibson completed her clinical studies at North Carolina State University School of Veterinary Medicine and officially graduated from Ross University in May 2010.

She is the Director of Clinical Studies at Assisi Animal Health.

Dr. Millichamp was a staff ophthalmologist at the Veterinary Medical Teaching Hospital, and faculty member in the Department of Small Animal Clinical Studies at the College of Veterinary Medicine, Texas A&M University from 1986 until 2009.

All Ingredients Backed By Clinical Studies At The Right Dosages To Deliver Results

There are no clinical studies at all, just marketing fluff.

Proven by clinical studies at University of Texas, Penn State College of Medicine, Colorado State University, California State University and hundreds of people like you: New Research Reveals «Secret Shortcut» You Can Use To BURN OFF MORE FAT and LOSE MORE WEIGHT without exercising longer or harder!

The team expects to pursue these findings further in clinical studies at Roswell Park.

The effect of gene therapy equaled that of a drug called VTS - 270, which has been evaluated in preclinical and clinical studies at numerous academic labs.

Komek manages the execution and regional strategy of clinical studies at Medtronic.

A new clinical study at the University of Michigan Health System will test the ability of a once daily dose of doxycycline to reduce the growth of small abdominal aortic aneurysms.

In a 21 - day clinical study at the University of North Carolina, PeakO ₂ ™ user's improved their time to exhaustion by an incredible 70 seconds from baseline; the placebo group improved only 5 seconds from baseline!

Ava completed a year - long clinical study at the University Hospital of Zurich under the lead of Prof. Dr. Brigitte Leeners, the leading expert on the mathematical modeling of menstrual cycles.

Karsten Schober, DVM, Ph.D., recently concluded a clinical study at Ohio State University that sought to utilize cardiac ultrasound to identify and stage congestive heart failure (CHF) in dogs.

NovaVive Inc. announced that its anticancer immunotherapeutic for horses will be evaluated in a clinical study at Iowa State University College of Veterinary Medicine.

Not exact matches

«We had been offering our Depression Care service for a number of years, and we wanted to dig into our data and measure our impact... look and see who our end users were,» says Barb Vader, Vice President, Clinical Services at Morneau Shepell, and the study's research lead.

The striking example I focused on then was the cancer drug Avastin, developed by Genentech (now Roche)-- which, at the time, had been studied in at least 400 completed human clinical trials for various cancers.

Many people believe that eating early in the morning will jumpstart your metabolism or that eating late at night will widen your waist because it's already asleep, but this study from the American Journal of Clinical Nutrition concluded that's a false claim.

Even the glitteriest of gold - standard clinical trials, for instance, are often undone by a leaden follow - up study that has the nerve to arrive at a different result.

Some retrospective studies and preclinical work have indicated that it might also lower a person's risk of cancer, though at least one clinical trial wasn't able to show that it had any protective effect on esophageal cancer.

«It's all about shaping the child's behavior,» says Dr. Andrea Vazzana, clinical assistant professor of child psychiatry at New York University Langone's Child Study Center.

WebMD cites a study led by Laura Berman, Ph.D., assistant clinical professor of psychiatry and ob - gyn at Northwestern University's Feinberg School of Medicine, which studied 2,000 couples.

Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.

Woo counters that Maastricht University in the Netherlands is currently conducting a clinical trial studying his company's supplements, which will publish at ClinicalTrials.gov.

Studies — including at least one clinical trial with 100 participants — have found that this diet can significantly alter signs of disease, reduce weight and body fat, lower blood pressure, decrease levels of biomarkers associated with cancer, and improve blood - sugar levels.

There are about 120 studies ongoing in Israel, including clinical trials looking at the effects of cannabis on autism, epilepsy, psoriasis, and tinnitus.

A study in the «Journal of Clinical Sleep Medicine» found that employees who weren't exposed to natural light at work slept an average of 46 minutes less a night than their peers with windows — and the sleep they did get was less restful.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«[A.I.] can help analyze large data sets from sources such as clinical trials, health records, genetic profiles, and preclinical studies; within this data, it can recognize patterns and trends and develop hypotheses at a much faster rate than researchers alone,» says Deloitte.

Following intensive study with Rosemary Gladstar and at the Dominion Herbal College, she became a chartered herbalist and clinical practitioner.

Attendees will learn through case studies how a PBM can engage all care stakeholders collaboratively - prescribers at the point of care (PoC), pharmacists at the point of sale (PoS), patients, and payers» clinical / pharmacy staff to reduce overall pharmacy costs and avoidable drug — impacted medical costs while improving compliance and patients» quality of life.

Attendees will learn through case studies how a PBM can engage all care stakeholders collaboratively — prescribers at the point of care (PoC), pharmacists at the point of sale (PoS), patients, and payers» clinical / pharmacy staff to reduce overall pharmacy costs and avoidable drug - impacted medical costs while improving compliance and patients» quality of life.

A recent study looked at how 244 compounds in 413 clinical trials fared for Alzheimer's disease between 2002 and 2012.

A Psychology Today study showed that millennials are reporting the highest levels of clinical anxiety, stress and depression of any other generation at the same age.

«The benefits of probiotics are strain specific, which means formulators need to look at the clinical studies supporting the exact probiotic strain used to determine what benefits to claim, and ensure inclusion rates through the end of shelf life to support these amounts,» Bush says.

In a study published in Clinical Biochemistry, 2004, researchers looked at coconut oil as a component of diet in laboratory animals.

Using data from clinical food challenge studies, the VSEP has identified reference doses for the common food allergens at which 95 - 99 % of the allergic population are unlikely react (1,2).

A clinical study was conducted in1999 - 2000 at Waikato Hospital in Hamilton, New Zealand using UMF ® Manuka Honey on unresponsive skin ulcers and chronic infected wounds.

A 2010 meta - study published in the American Journal of Clinical Nutrition looked at almost 350,000 people over a 23 year period and found no association between saturated fat and heart disease.

One the largest analysis of the peer - reviewed literature was published in The American Journal of Clinical Nutrition in 2010, and this meta - analysis looked at almost 350,000 studies published on saturated fats, and concluded:

The full report as well as links to clinical study findings can be found on RBT's home page at www.ricebrantech.com.

Polished seeds were stored at — 80 °C until shipped to Boston, where they were cooked and analyzed before the clinical studies.

A 2005 study in the American Journal of Clinical Nutrition found that consuming almonds as part of a heart - healthy diet can be just as effective at lowering LDL «bad» cholesterol levels as first generation statin drugs.

Giroud does not deserve to lead the arsenal line next season.He should be replaced do u know why?It is because he is always going to miss a lot of chances and will cost us.people who support him to lead the line have not studied his game clearly.every season he will continue to cost us.But at least i wont say he is useless or something.He is on the pitch and gives his all so he is useful.He is not clinical and not good at all.He is a striker who is just above average but sometimes even performs below average in his 3 years over here.Be honest and say it as it is.Some people use stats to constantly defend him yet if you watch him you will be shocked.Walcott can lead the line he has everything to.but as i said he lacks the aggressiveness and physique to be the main man.that will go against him so many times.so its better for him to remain on the wings.Giroud does not deserve it.We all know that.

Despite finding that underreporting continues to be what she wrote in two 2013 studies to be an «alarming» [17] and «overwhelming» problem, [16] Johna Register - Mihalik, Ph.D, LAT, ATC, Senior Research Associate at WakeMed and Adjunct Assistant Professor at UNC - Chapel Hill, told MomsTEAM that the the reason the use of impact sensors was not among the recommendations she and her co-authors in those studies made to address the problem of chronic underreporting was that she viewed «the use of impact sensors in concussion detection, as the science, although a growing field of information, is just not quite there in how these may best be used from a clinical standpoint and across all sport settings.»

Co-sleeping is probably the most controversial aspect of attachment parenting, according to Virginia Shiller, a licensed clinical psychologist and lecturer at the Yale (University) Child Study Center.

* While there are, as of yet, no clinical studies to confirm the results, a laboratory study conducted at the College of Pharmacy at Oregon State University (OSU) presented at a December 2007 meeting of the American Society of Health - System Pharmacists found that an ointment containing benzethonium chloride with tea tree and white thyme oil worked best against all four tested MRSA strains, while ointments containing neomycin, polymyxin, and gramicidin also had some antibacterial effectiveness.

Despite finding that underreporting continues to be what she wrote in two 2013 studies to be an «alarming» and «overwhelming» problem, Dr. Johna Register - Mihalik, a research scientist and member of the faculty at the Matthew Gfeller Sport - Related TBI Research Center at the University of North Carolina at Chapel Hill, recently told MomsTEAM that the reason she and her colleagues did not recommend the use of impact sensors in addressing the problem was that she viewed «the use of impact sensors in concussion detection, as the science, although a growing field of information, [as] just not quite there in [terms of] how the [y] may best be used from a clinical standpoint and across all sport settings.»

One recent study in the «Journal of Clinical Epidemiology» showed that women who nursed babies for at least 25 months total of their own life had a decreased risk compared to mothers who did not nurse.

«You can not find a number for this,» says Marianne Neifert, a clinical professor of pediatrics at the University of Colorado Denver School of Medicine who co-authored a 1990 study of 319 breast - feeding women that found 15 percent of the women were unable to produce sufficient milk by three weeks postpartum.

Another clinical study (Ishii 2009), conducted in Japan, looked at 110 women who overlapped breastfeeding and pregnancy and compared them to 774 who did not.